Literature DB >> 10646902

Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro.

M Dettke1, H Loibner.   

Abstract

Stimulation of monocytes by interaction of monoclonal antibodies (mAbs) with Fc gamma receptors (FcgammaRs) results in the activation of various monocyte effector functions. In the present investigation we show that the anti-Lewis Y (LeY) anti-tumour mAb ABL 364 and its mouse/human IgG1 chimaera induce both antibody-dependent cellular cytotoxicity (ADCC) and the release of tumour necrosis factor alpha (TNF-alpha) during mixed culture of monocytes with LeY+ SKBR5 breast cancer cells in vitro. Although anti-LeY mAb-mediated TNF-alpha release paralleled ADCC activity, cytokine release required a higher concentration of sensitizing mAb than the induction of cytolysis. The determination of the FcgammaR classes involved in the induction of the distinct effector functions showed that anti-LeY mAb-induced cytolysis was triggered by interaction between anti-LeY mAbs and FcgammaRI. In contrast, mAb-induced TNF-alpha release mainly depended on the activation of monocyte FcgammaRII. Neutralization of TNF-alpha showed no influence on monocyte ADCC activity towards SKBR5 target cells. Our data indicate an independent regulation of anti-LeY mAb induced effector functions of ADCC and TNF-alpha release which seemed to be triggered by activation of different types of FcgammaR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10646902      PMCID: PMC2363301          DOI: 10.1054/bjoc.1999.0940

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Activity of two types of Fc receptors, Fc gamma RI and Fc gamma RII, in human monocyte cytotoxicity to sensitized erythrocytes.

Authors:  J G van de Winkel; G J Boonen; P L Janssen; A Vlug; N Hogg; W J Tax
Journal:  Scand J Immunol       Date:  1989-01       Impact factor: 3.487

2.  Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase.

Authors:  J M Debets; J G Van de Winkel; J L Ceuppens; I E Dieteren; W A Buurman
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

3.  Rapid isolation of plasma membranes in high yield from cultured fibroblasts.

Authors:  D Thom; A J Powell; C W Lloyd; D A Rees
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

4.  Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.

Authors:  P M Guyre; R F Graziano; B A Vance; P M Morganelli; M W Fanger
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

5.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

Authors:  K C Petroni; L Shen; P M Guyre
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

6.  Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis.

Authors:  R Jänicke; D N Männel
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

7.  Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses.

Authors:  D R Shaw; M B Khazaeli; A F LoBuglio
Journal:  J Natl Cancer Inst       Date:  1988-12-07       Impact factor: 13.506

8.  Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.

Authors:  J H Boot; M E Geerts; L A Aarden
Journal:  J Immunol       Date:  1989-02-15       Impact factor: 5.422

9.  The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29.

Authors:  S Bungard; D Flieger; S Schweitzer; T Sauerbruch; U Spengler
Journal:  Cancer Immunol Immunother       Date:  1998-06       Impact factor: 6.968

10.  Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy.

Authors:  M Blaszczyk-Thurin; J Thurin; O Hindsgaul; K A Karlsson; Z Steplewski; H Koprowski
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

View more
  4 in total

1.  Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314.

Authors:  Ralf Kircheis; Nicole Halanek; Iris Koller; Wolfgang Jost; Manfred Schuster; Gilbert Gorr; Klaus Hajszan; Andreas Nechansky
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

Review 2.  Antibodies: At The Nexus of Antigens and Cancer Vaccines.

Authors:  Zenon Steplewski; Magdalena Thurin; Thomas Kieber-Emmons
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

Review 3.  Adoptive T-cell therapy for Leukemia.

Authors:  Haven R Garber; Asma Mirza; Elizabeth A Mittendorf; Gheath Alatrash
Journal:  Mol Cell Ther       Date:  2014-08-12

Review 4.  Genetics Insight for COVID-19 Susceptibility and Severity: A Review.

Authors:  Ingrid Fricke-Galindo; Ramcés Falfán-Valencia
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.